Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of dexamethasone, IVIG and interferon beta for severe COVID-19
IRCT20120225009124N4Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone, immune globulin and interferon beta-1a in coronavirus disease 2019 (COVID-19), sponsored by Golestan University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
dexamethasoneimmune globulininterferon beta-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20120225009124N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120225009124N4.